Byun HJ - Search Results

1

An evaluation of the neonatal immune system using a listeria infection model.

Byun HJ, Jung WW, Lee JB, Chung HY, Sul D, Kim SJ, Park CG, Choi I, Hwang KW, Chun T. Byun HJ, et al. Neonatology. 2007;92(2):83-90. doi: 10.1159/000100806. Epub 2007 Mar 14. Neonatology. 2007. PMID: 17361091

2

The effect of soluble LAG-3 (CD223) treatment in fetal thymic organ culture.

Chun T, Byun HJ, Chung HY, Chung YH. Chun T, et al. Among authors: byun hj. Biotechnol Lett. 2004 Sep;26(17):1371-7. doi: 10.1023/B:BILE.0000045635.63873.96. Biotechnol Lett. 2004. PMID: 15604766

3

The polycomb group gene product Mel-18 interacts with cyclin D2 and modulates its activity.

Chun T, Rho SB, Byun HJ, Lee JY, Kong G. Chun T, et al. Among authors: byun hj. FEBS Lett. 2005 Oct 10;579(24):5275-80. doi: 10.1016/j.febslet.2005.08.050. FEBS Lett. 2005. PMID: 16182291 Free article.

4

Collagen scaffolds derived from a marine source and their biocompatibility.

Song E, Yeon Kim S, Chun T, Byun HJ, Lee YM. Song E, et al. Among authors: byun hj. Biomaterials. 2006 May;27(15):2951-61. doi: 10.1016/j.biomaterials.2006.01.015. Epub 2006 Feb 2. Biomaterials. 2006. PMID: 16457878

5

Proliferation of activated CD1d-restricted NKT cells is down-modulated by lymphocyte activation gene-3 signaling via cell cycle arrest in S phase.

Byun HJ, Jung WW, Lee DS, Kim S, Kim SJ, Park CG, Chung HY, Chun T. Byun HJ, et al. Cell Biol Int. 2007 Mar;31(3):257-62. doi: 10.1016/j.cellbi.2006.11.002. Epub 2006 Nov 14. Cell Biol Int. 2007. PMID: 17175182

6

Calpain 6 supports tumorigenesis by inhibiting apoptosis and facilitating angiogenesis.

Rho SB, Byun HJ, Park SY, Chun T. Rho SB, et al. Among authors: byun hj. Cancer Lett. 2008 Nov 28;271(2):306-13. doi: 10.1016/j.canlet.2008.06.020. Epub 2008 Jul 26. Cancer Lett. 2008. PMID: 18657900

7

Soluble pig lymphocyte activation gene-3 (LAG-3; CD223) inhibits human-to-pig xenogeneic mixed lymphocyte reaction.

Kim SS, Byun HJ, Kim SH, Lee HH, Lee SJ, Kim SJ, Park CG, Chun T. Kim SS, et al. Among authors: byun hj. Biotechnol Lett. 2010 Feb;32(2):203-8. doi: 10.1007/s10529-009-0144-9. Epub 2009 Oct 16. Biotechnol Lett. 2010. PMID: 19834647

8

Anti-apoptotic protein TCTP controls the stability of the tumor suppressor p53.

Rho SB, Lee JH, Park MS, Byun HJ, Kang S, Seo SS, Kim JY, Park SY. Rho SB, et al. Among authors: byun hj. FEBS Lett. 2011 Jan 3;585(1):29-35. doi: 10.1016/j.febslet.2010.11.014. Epub 2010 Nov 17. FEBS Lett. 2011. PMID: 21081126 Free article.

9

CYR61 controls p53 and NF-κB expression through PI3K/Akt/mTOR pathways in carboplatin-induced ovarian cancer cells.

Lee KB, Byun HJ, Park SH, Park CY, Lee SH, Rho SB. Lee KB, et al. Among authors: byun hj. Cancer Lett. 2012 Feb 1;315(1):86-95. doi: 10.1016/j.canlet.2011.10.016. Epub 2011 Oct 21. Cancer Lett. 2012. PMID: 22078465

10

PDCD6 additively cooperates with anti-cancer drugs through activation of NF-κB pathways.

Park SH, Lee JH, Lee GB, Byun HJ, Kim BR, Park CY, Kim HB, Rho SB. Park SH, et al. Among authors: byun hj. Cell Signal. 2012 Mar;24(3):726-33. doi: 10.1016/j.cellsig.2011.11.006. Epub 2011 Nov 12. Cell Signal. 2012. PMID: 22142513

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139 results

Search Page

Filters